How did Zene360 genome analysis results impact daily step counts in Dr. Yoshitaka Hashimoto's study presented at the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism?

The study showed that health counseling using Zene360 genome analysis significantly increased daily step counts among participants.

What specific dietary change was observed in participants who received counseling based on Zene's Zene360 genetic results during the Matsushita Memorial Hospital trial?

Participants demonstrated a significant reduction in lipid intake after receiving counseling with Zene360 genome analysis results.

Which product by Zene was used in the behavioral intervention study presented at the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism?

The Zene360 genome analysis product was used in the behavioral intervention study conducted by Matsushita Memorial Hospital.

Who conducted the Zene360 genome analysis study that was presented at the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism?

Dr. Yoshitaka Hashimoto and colleagues at Matsushita Memorial Hospital conducted the Zene360 genome analysis study.

What type of clinical trial evaluated the effectiveness of Zene360 in promoting lifestyle changes at the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism?

An exploratory randomized controlled trial assessed the effectiveness of Zene360 in encouraging positive behavioral changes.

AI News NQ Analysis

Potential for Lifestyle-Related Disease Prevention Through Behavioral Change Using Zene360 Genome Analysis Results Presented at the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism

NQ Score 100/100

AI Summary (NQ-processed)

At the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism, a study by Dr. Yoshitaka Hashimoto and colleagues at Matsushita Memorial Hospital demonstrated that health counseling incorporating Zene's 'Zene360' genome analysis results significantly increased daily step counts and reduced lipid intake. This exploratory randomized controlled trial suggests that utilizing personalized genetic information can effectively encourage positive behavioral changes for lifestyle-related disease prevention.

AI analysis data is not yet available.

Frequently Asked Questions

Q: How did Zene360 genome analysis results impact daily step counts in Dr. Yoshitaka Hashimoto's study presented at the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism?: A: The study showed that health counseling using Zene360 genome analysis significantly increased daily step counts among participants.
Q: What specific dietary change was observed in participants who received counseling based on Zene's Zene360 genetic results during the Matsushita Memorial Hospital trial?: A: Participants demonstrated a significant reduction in lipid intake after receiving counseling with Zene360 genome analysis results.
Q: Which product by Zene was used in the behavioral intervention study presented at the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism?: A: The Zene360 genome analysis product was used in the behavioral intervention study conducted by Matsushita Memorial Hospital.
Q: Who conducted the Zene360 genome analysis study that was presented at the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism?: A: Dr. Yoshitaka Hashimoto and colleagues at Matsushita Memorial Hospital conducted the Zene360 genome analysis study.
Q: What type of clinical trial evaluated the effectiveness of Zene360 in promoting lifestyle changes at the 41st Annual Meeting of the Japanese Society for Clinical Nutrition and Metabolism?: A: An exploratory randomized controlled trial assessed the effectiveness of Zene360 in encouraging positive behavioral changes.